RSNA 2009 

Abstract Archives of the RSNA, 2009


SSG04-08

Tumor Response Evaluation in Patients with Advanced Lung Cancer: Measurement Reproducibility of Semiautomated Volumetric Measurement

Scientific Papers

Presented on December 1, 2009
Presented as part of SSG04: Chest (Malignancy)

Participants

Hyun Ju Lee MD, Presenter: Nothing to Disclose
Jin Mo Goo MD, PhD, Abstract Co-Author: Nothing to Disclose
Chang Min Park, Abstract Co-Author: Nothing to Disclose
Chang Hyun Lee MD, Abstract Co-Author: Nothing to Disclose
Jung Im Kim MD, Abstract Co-Author: Nothing to Disclose
So Young Choi MD, Abstract Co-Author: Nothing to Disclose
Youkyung Lee MD, Abstract Co-Author: Nothing to Disclose
00030490-DMT et al, Abstract Co-Author: Nothing to Disclose

PURPOSE

To evaluate the inter-observer reproducibility of semiautomated volumetic measurement for evaluation of tumor response after chemotherapy in patients with advanced lung cancer

METHOD AND MATERIALS

21 patients (M:F=14:7, mean age 62) with advanced lung cancer prospectively underwent 1-mm thick whole-body CT covering from neck to pelvis before and after systemic chemotherapy. Using commercial software (Syngo oncology, Siemens), the volumes of all cancer lesions including lung mass, lymph nodes (LNs), and solid organ metastasis were measured and the volume of whole body lesions were added. Response to treatment after chemotherapy was evaluated by calculation of change in the volume of whole body lesions. The measurement was performed by three readers (reader A, B, and C). Inter-observer measurement reproducibility for evaluation of tumor response was assessed using coefficients of variation (CV).

RESULTS

26 lung masses, 19 LNs, one adrenal mass, and one liver mass were measured. Semiautomated volumetic measurement was feasible in all lesions. The mean number of manual correction for segmentation of lesions from surrounding structures was 1.04 for lung masses, 2.32 for LNs, and 1.32 for solid organ masses. In the evaluation of tumor response in lung masses, the inter-observer averaged CVs between readers A-B, A-C, and B-C were 17.7%, 19.6%, and 23.2%. In LNs, the averaged CVs between readers A-B, A-C, and B-C were 25.1%, 29.1%, and 28.5%. In the evaluation of whole body lesions, the averaged CVs between readers A-B, A-C, and B-C were 20.6%, 23.4%, and 25.8%.

CONCLUSION

Tumor response evaluation using semiautomated volumetic measurement was feasible. The inter-observer reproducibility was higher in the measurement of lung masses than in the measurement of LNs.

CLINICAL RELEVANCE/APPLICATION

Computer-assisted semiautomated volumetic measurement could be applied to the evaluation of tumor response in patients with advanced lung cancer.

Cite This Abstract

Lee, H, Goo, J, Park, C, Lee, C, Kim, J, Choi, S, Lee, Y, et al, 0, Tumor Response Evaluation in Patients with Advanced Lung Cancer: Measurement Reproducibility of Semiautomated Volumetric Measurement.  Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8015215.html